Am J Infect Control 1999, 27(2):97–132.PubMedCrossRef 2. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW: Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen 2011, 19(1):1–9.PubMedCrossRef 3. Stewart PS, Costerton JW: Antibiotic resistance

of bacteria in biofilms. Lancet 2001, 358:135–138.PubMedCrossRef 4. Hoyle BD, Costerton JW: Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991, 37:91–105.PubMed 5. Phillips CB, Barrett JA, Losina E, Mahomed NN, Lingard EA, Guadagnoli E, Baron JA, Harris WH, Poss R, Katz JN: click here Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 2003, 85-A(1):20–26.PubMed 6. Spangehl MJ, Masri BA, O’Connell JX, Duncan CP: Prospective analysis of preoperative and intraoperative

investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999, 81(5):672–683.PubMed 7. Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ: Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2651 hip operations. Acta Orthop Scand 1992, 63(6):665–671.PubMed 8. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ: Selleck Entinostat The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am 2009, 91(1):128–133.PubMedCrossRef 9. Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ: The epidemiology of revision total knee arthroplasty in the

United States. Clin Orthop Relat Res 2010, 468(1):45–51.PubMedCrossRefPubMedCentral 10. Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, Masselink LE, Kaye KS, Corey GR, Reller LB, Stryjewski ME, Schulman KA, Fowler VG Jr: Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med 2005, 118(12):1416.PubMedCrossRef 11. GSK1904529A supplier Tsukayama DT, Estrada R, Gustilo RB: Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996, 78(4):512–523.PubMed 12. Zimmerli W, Ochsner PE: Management of infection associated with prosthetic joints. Infection 2003, 31(2):99–108.PubMedCrossRef PLEK2 13. Mack D, Davies AP, Harris LG, Rohde H, Horstkotte MA, Knobloch JK: Microbial interactions in Staphylococcus epidermidis biofilms. Anal Bioanal Chem 2007, 387:399–408.PubMedCrossRef 14. Götz F: Staphylococcus and biofilms. Mol Microbiol 2002, 43(6):1367–1378.PubMedCrossRef 15. Hori K, Matsumoto S: Bacterialadhesion: From mechanism to control. Biochem Eng J 2010, 48(3):424–434.CrossRef 16. An YH, Friedman RJ: Concise review of mechanisms of bacterial adhesion to biomaterial surfaces. J Biomed Mater Res 1998, 43(3):338–348.PubMedCrossRef 17.